Canada defeats NAFTA claim over pharma patents
Canada has defeated a US$374 million NAFTA claim brought by US drugmaker Eli Lilly over the revocation of two drug patents.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10